EP Wealth Advisors LLC purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 40,569 shares of the financial services provider's stock, valued at approximately $6,762,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Ieq Capital LLC bought a new position in shares of Marsh & McLennan Companies in the second quarter valued at about $13,905,000. Callan Family Office LLC bought a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth about $11,100,000. Expressive Wealth LLC acquired a new position in Marsh & McLennan Companies in the 2nd quarter valued at about $340,000. Keating Financial Advisory Services Inc. bought a new position in Marsh & McLennan Companies in the 2nd quarter valued at about $41,000. Finally, OneAscent Family Office LLC acquired a new stake in Marsh & McLennan Companies during the second quarter worth approximately $405,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other Marsh & McLennan Companies news, SVP Paul Beswick sold 713 shares of the stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $198.00, for a total transaction of $141,174.00. Following the sale, the senior vice president directly owned 16,376 shares in the company, valued at $3,242,448. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Lloyd M. Yates sold 12,000 shares of the firm's stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the completion of the transaction, the director directly owned 12,001 shares in the company, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 36,469 shares of company stock worth $6,291,345. 0.38% of the stock is owned by company insiders.
Marsh & McLennan Companies Price Performance
Shares of NYSE:MRSH opened at $192.17 on Friday. The business's 50 day moving average is $179.88. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $212.65. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $91.71 billion, a P/E ratio of 23.49, a P/E/G ratio of 2.73 and a beta of 0.59.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.89 by $0.07. The firm had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The firm's revenue was up 6.2% on a year-over-year basis. On average, sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were paid a $0.99 dividend. This represents a $3.96 dividend on an annualized basis and a yield of 2.1%. This is a boost from Marsh & McLennan Companies's previous quarterly dividend of $0.90. The ex-dividend date of this dividend was Thursday, July 23rd. Marsh & McLennan Companies's payout ratio is presently 48.41%.
Analyst Upgrades and Downgrades
MRSH has been the topic of a number of recent research reports. Morgan Stanley increased their target price on Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an "equal weight" rating in a research note on Wednesday. UBS Group upped their price objective on Marsh & McLennan Companies from $212.00 to $216.00 and gave the company a "buy" rating in a report on Monday, July 27th. Cantor Fitzgerald increased their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. Mizuho boosted their target price on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a "neutral" rating in a research report on Wednesday, July 22nd. Finally, Wells Fargo & Company upped their price target on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an "equal weight" rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $203.50.
View Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.